US 7585841
Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src
granted A61KA61K38/00A61K48/00
Quick answer
US patent 7585841 (Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/00, A61K48/00, A61P, A61P19/02